British Regen Industry Tool Set (BRITS)

Lead Participant: LONZA BIOLOGICS PLC

Abstract

The British Regen Industry Tool Set (BRITS) is an industry driven project aimed at establishing reliable market data and creating both detailed bioprocess economics models and higher level business models for integration into a highly valuable and timely set of decisional tools. The individual components will themselves be highly novel, and the final integrated tool set will be a major step change for the cell therapy industry. BRITS will encompass the entire supply chain. This will including direct links through the main innovation routes available within the NHS. Via its wider business benefit activities BRITS will interact with all the UK stakeholders to facilitate the uptake of the outputs of the project and build and maintain the vital linkages between the diverse stakeholders in order to promote the joined-up approach that will be required if the UK is to be at the international forefront of cell therapy, not just scientifically but also commercially.

Lead Participant

Project Cost

Grant Offer

LONZA BIOLOGICS PLC £506,959 £ 200,000
 

Participant

LONDON REGENERATIVE MEDICINE NETWORK £110,625 £ 110,625
UNIVERSITY COLLEGE LONDON
UNIVERSITY COLLEGE LONDON £709,921 £ 709,921
LGC LIMITED £99,308 £ 49,654
NHS TECHNOLOGY ADOPTION CENTRE £22,129
FUTURE MEDICINE LIMITED £256,562 £ 129,375

People

ORCID iD

Publications

10 25 50